Phase III clinical trials for Abdala vaccine candidate authorized
The phase III trial for Abdala, from the Center for Genetic Engineering and Biotechnology (CIGB), will take place in the ...
The phase III trial for Abdala, from the Center for Genetic Engineering and Biotechnology (CIGB), will take place in the ...
“At the latest, in August we will have manufactured the doses required to immunize our entire population, and then we ...
The excellent results obtained so far with the Cuban vaccine candidate in phases I and II have allowed it to ...
Dr. Dagmar García Rivero, director of research at the Finlay Vaccine Institute, affirmed that in order to achieve high immunization ...
In addition to Guantánamo, the effectiveness study covers the provincial capital of Santiago de Cuba.
The island is preparing to begin the third phase of clinical trials of its vaccine candidates Soberana 02, in Havana, ...
Havana’s ambassador in Paramaribo announced this “possibility” during a meeting with the leader of the National Party (NPS), Gregory Rusland, ...
The president of BioCubaFarma, Eduardo Martínez, announced this Wednesday on his Twitter account the start of the manufacturing at Aica ...
The general director of the Finlay Vaccine Institute, Dr. Vicente Vérez, affirmed that this Cuban vaccine candidate has demonstrated a ...
The country’s most advanced Cuban prototype COVID-19 vaccine is due to enter phase III of clinical trials in March.
Volunteers from Mexico could participate in the clinical trials of the Cuban Soberana 02 COVID-19 vaccine candidate, according to that ...
The president of the Biotechnologic and Pharmaceutical Industries Group (BioCubaFarma), Eduardo Martínez Díaz, affirmed this Thursday in the Mesa Redonda ...
Cuba plans to begin trials on minors at the end of February with the Soberana 01 and Soberana 02 COVID-19 ...
The Cuban Abdala COVID-19 vaccine candidate will begin the second phase of clinical trials on February 1, the official media ...
The Abdala vaccine candidate, one of the four Cuban COVID-19 vaccines currently in clinical trial, is showing favorable results in ...
Cuba is carrying out a clinical trial in people convalescing from COVID-19, who had a minor clinical picture or were ...
Cuba will produce this year 100 million doses of its Soberana 02 vaccine against the new coronavirus in order to ...
The clinical trial of the Cuban Abdala COVID-19 vaccine candidate in the eastern province of Santiago de Cuba―one of the ...
Cuba and Iran signed a bilateral agreement this Friday that establishes an alliance in the work for the development of ...
Cuba is negotiating to develop in other countries the last phase of trials of one of its four vaccine projects ...
After having approved phase 2 of clinical trials of its second vaccine candidate to prevent COVID-19, called Soberana 02, Cuba ...
Cuba approved the second phase of clinical trials for its Soberana 02 COVID-19 vaccine candidate after registering preliminary positive results ...
The clinical trial of the Abdala vaccine candidate, one of the four developed by Cuban scientists against COVID-19, began this ...
Cuba began a new clinical trial aimed at curing the COVID-19 disease, produced by the SARS-CoV-2 virus, which to date ...
Executives of the Finlay Vaccine Institute presented this Wednesday the progress of the Cuban COVID-19 vaccine candidate, Soberana 01, during ...
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.